Medica 2026
Nov 16-19, 2026 - Düsseldorf, Germany
ADLM 2026
July 26-30, 2026 – Anaheim, CA, USA

What is BK Virus (BKV)?

BK virus is the full name of BKV which represents a small DNA virus researchers discovered in 1971. Researchers named the virus based on the initials of the first patient who tested positive. During clinical diagnosis, BK virus is often confused with Mycobacterium tuberculosis although it does not share the same genus. The BK virus is part of the Polyomavirus family together with human JC virus and simian SV40 virus among other viruses. People with normal immune functions host inactive BK virus while immunocompromised individuals like organ transplant recipients and chemotherapy or AIDS patients might experience severe urinary and neurological complications from the virus.

Western Blot detection against VP1.

Anti-BKV VP1 Monoclonal antibody

Quick Inquiry→

Discover More:

Mouse Anti-BKV VP1 Monoclonal antibody, clone 4C3

Rabbit Anti-BKV VP1 Monoclonal Antibody, clone NEG447A

Human Anti-BKV VP1 Monoclonal Antibody, clone NEG447A

Polyomavirus Major Capsid VP1 (full length)

Polyomavirus Major Capsid VP1 (full length)

Virological Characteristics

The BK virus takes on a non-enveloped arrangement and possesses a 40-nanometer structure with icosahedral symmetry. The BK virus genome structure includes a circular double-stranded DNA molecule that measures approximately 5 kilobases and contains three primary sections.

  • Early Coding Region: The virus produces significant amounts of large T antigen (T-Ag), small t antigen (t-Ag), and truncated T antigen (truncT-Ag) which stimulate tumorigenic activities while pushing host cells into the S phase to duplicate its viral DNA.
  • Late Coding Region: The BK virus genome includes the main capsid protein VP1 along with two additional capsid proteins VP2 and VP3 and the helper protein agnoprotein.
  • Non-Coding Control Region (NCCR): The Non-Coding Control Region (NCCR) manages both the transcription process and replication of the two coding areas discussed earlier.

Mature viral particles develop their capsid structure through 72 VP1 pentamers that associate with VP2 or VP3 proteins. The different BK virus genotypes I through IV result from antigenic variations in the VP1 protein, with genotype I showing the highest prevalence. The distribution of BK virus genotypes is influenced by ethnicity and age along with HIV co-infection.

Epidemiology and Transmission

BK virus exists only in humans throughout the world without seasonal patterns or socioeconomic influences. Adults worldwide show a seroprevalence rate between 80% and 90% as initial BK virus infections often occur in asymptomatic children aged four and younger.

Transmission routes include:

  • Respiratory Transmission: (e.g., tonsillar carriers in children)
  • Fecal-oral and Urinary Transmission: The virus actively replicates in the urine samples of pregnant women and individuals who are either elderly or immunocompromised.
  • Bloodborne Transmission: (Virus is present in white blood cells)
  • Sexual Transmission: (Semen carries the virus)
  • Environmental Transmission: (Water contamination serves as an important reservoir)

Latency and Reactivation Mechanism

The BK virus remains latent in several body tissues including renal tubular epithelial cells and urinary tract epithelium as well as white blood cells and sperm after the initial infection. The virus remains dormant in people with healthy immune systems but sometimes causes short-lived low-level viremia. The virus reactivates in immunocompromised patients which include organ transplant recipients and HIV/AIDS patients as well as chemotherapy patients and pregnant women leading to high replication levels and related pathological effects.

The body's T-cell responses within cell-mediated immunity serve as a critical defense against BK virus. The concentration of CD4+ T cells demonstrates an inverse relationship with the amount of viral shedding.

A native renal biopsy with multiple intranuclear BK viral inclusions (Gupta N, 2015)Figure 1. A native renal biopsy with multiple intranuclear BK viral inclusions (Source: Gupta N, et al. 2015)

Clinical-Related Diseases

  • BK virus causes Renal Transplant-Associated Nephropathy (BKVAN) which emerges as one of the most severe and prevalent clinical conditions found in kidney transplant recipients. Acute interstitial nephritis develops when the virus begins to replicate within the renal tubular epithelial cells of transplanted kidneys. Without timely diagnosis and treatment, the condition could result in the loss of the transplanted kidney.
    • Incidence: Viral urinary shedding occurs in 80% of kidney transplant patients while 10% develop BKVAN.
    • Risk of Kidney Loss: Study results show that the reported rates vary from 15% to 100%.
    • Risk Factors: HLA mismatch, anti-calcineurin nephrotoxicity, pre-transplant BK seronegativity along with diabetes and age factored together with male gender and Caucasian race contribute to risk factors.
  • Hematopoietic stem cell transplant (HSCT) patients frequently develop Hemorrhagic Cystitis (BKVHC) with an occurrence rate between 5% and 60%. Two weeks after transplant patients usually develop symptoms that include hematuria along with bladder inflammation. The disease process emerges from intense local inflammatory reactions triggered by the replication of the virus in cells lining the urinary tract. The presence of BK virus at high levels in urine demonstrates elevated risk yet the detection of viral DNA in blood holds higher predictive significance.
  • The central nervous system of severely immunocompromised individuals with AIDS may experience BK virus reactivation that causes meningoencephalitis on rare occasions. The symptoms match those of progressive multifocal leukoencephalopathy (PML) while histological analysis reveals no involvement of oligodendrocytes. PCR research reveals BK virus DNA in both cerebrospinal fluid samples and brain tissue biopsy samples.
  • BK virus exhibits rare manifestations such as pneumonia, retinitis, colitis and vasculitis which appear mainly in severely immunocompromised patients like those with AIDS or individuals who have received multiple organ transplants.

Testing Tools for Research

Common BK virus detection methods include:

  • PCR
    The PCR technique detects viral DNA present in urine samples along with blood and cerebrospinal fluid specimens.
  • Virus Culture and Immunohistochemistry
    Assists with tissue pathological diagnosis.
  • Urine Sediment Cell Detection
    Early screening for kidney transplant recipients.
  • Serological Tests
    Assess past infection or immune status.
  • ELISA kits enable detection of BK virus antigens and antibodies and serve as fundamental instruments for virological research while evaluating immune responses and monitoring drug effectiveness in drug screening, vaccine research and viral infection studies.

Anti-polyomavirus BK (BKV) IgG ELISA Kit (DEIASL161)

Size
96T
Species Reactivity
Human
Application
Qualitative and semiquantitative
Detection Sample
serum and plasma

Quick Inquiry→

Research Outlook

The clinical importance of BK virus as a prevalent polyomavirus that poses high risks in immunocompromised settings has grown due to extensive organ transplant technology usage and immunotherapy treatments. The main research areas now include studying the virus's latency mechanisms and host immune evasion strategies as well as exploring viral connections to tumorigenesis and searching for early biomarkers and preventive methods.

Future developments in molecular diagnostics together with antiviral strategies and vaccine research will enable more precise personalized interventions to control and prevent BK virus-related diseases.

Simply Submit an Online Inquiry (click on the product details page and scroll to the bottom) to receive our dedicated support.

References

  1. Sigu Mier, Sellier P, Bergmann JF. BK-virus infections: A literature review. Médecine et Maladies Infectieuses. 2012;42(5):181-187.
  2. Gupta N, Lawrence R, Nguyen C, et al. Review article: BK virus in systemic lupus erythematosus. Pediatric Rheumatology. 2015;13:34.

BKV ELISA Kits

TargetCat. No.Product NameSizeSpeciesApplicationDetection Sample
BKVDEIASL161Anti-polyomavirus BK (BKV) IgG ELISA Kit96TSemi-quantitativeserum and plasmaInquiry

BKV Antibodies

TargetCat. No.Product NameHostIsotypeApplication
BKV VP1CABT-NS1131Rabbit Anti-BKV VP1 Monoclonal Antibody, clone NEG447ARabbitIgGELISAInquiry
CABT-NS1132Human Anti-BKV VP1 Monoclonal Antibody, clone NEG447AHumanIgG1ELISAInquiry
CABT-CS613Mouse Anti-BKV VP1 Monoclonal antibody, clone 4C3MouseIgG1 KappaWB, IHC, ELISAInquiry
Polyomavirus early antigenDMABT-Z60972Anti-Polyomavirus Early Antigen Monoclonal antibody, Clone RaERatIgG2bWB, IP, ICC, IFInquiry
Polyomavirus Large T antigenDMABT-Z59919Anti-Polyomavirus Large T antigen Monoclonal antibody, Clone RaLVRatIgG2bWB, IP, ICC, IFInquiry
Polyomavirus Medium TDMABT-Z60955Anti-Polyomavirus Medium T Monoclonal antibody, Clone RaOVRatIgG2bIP, ICC, IF, WBInquiry
Polyomavirus PyMTDMAB7134Anti-Polyomavirus PyMT Monoclonal antibody, Clone Hmv-HmvMouseIgG1IF, WB, IPInquiry

BKV Antigens

TargetCat. No.Product NameExpression SystemTag/ConjugateApplication
Polyomavirus Major Capsid VP1DAG-P2867Polyomavirus Major Capsid VP1 (full length)S. cerevisiaeKLHELISA, WB, SDS-PAGEInquiry
DAG-P2869Polyomavirus Major Capsid VP1 (full length)S. cerevisiaeKLHELISA, WB, SDS-PAGEInquiry
Inquiry Basket